Account
Inquiry
Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide demonstrates exceptional potential in metabolic research applications.
The Tirzepatide 20mg formulation appears as a white lyophilized powder with pharmaceutical-grade purity. Its unique mechanism of action simultaneously activates both GIP and GLP-1 receptors, making it particularly valuable for studying metabolic regulation pathways.
Research indicates Tirzepatide 20mg may support glucose homeostasis through multiple mechanisms: enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. These properties make it an important compound for metabolic disorder investigations.
Proper storage is essential for maintaining Tirzepatide 20mg stability. The lyophilized powder should be kept at -20°C in a sealed container with desiccant. For research solutions, aliquoting is recommended to avoid repeated freeze-thaw cycles.
This product is supplied as Tirzepatide 20mg per vial with purity verified by HPLC analysis. The material is strictly for research purposes and not intended for human consumption.
